Coronavirus Notebook: Heterologous Vaccine Study Shows Positive Results, UK Offers Earlier Second Dose To Vulnerable People
A Regime Of Two Different Vaccines Could Lead To More Flexible Vaccination Campaigns
Learn what's happening at the US FDA. On the go.
